Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Instituto do Cancer do Estado de São Paulo
AbbVie
Corcept Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OncoC4, Inc.
National Cancer Institute (NCI)
University of Colorado, Denver
Regeneron Pharmaceuticals
University of Washington
AbbVie
CanariaBio Inc.
Brown University
Dana-Farber Cancer Institute
CanariaBio Inc.
Memorial Sloan Kettering Cancer Center
University of Chicago
Second Affiliated Hospital, School of Medicine, Zhejiang University
Roswell Park Cancer Institute
Wake Forest University Health Sciences
Roswell Park Cancer Institute
University of California, Davis
National Cancer Institute (NCI)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
M.D. Anderson Cancer Center
North Eastern German Society of Gynaecological Oncology
Ohio State University Comprehensive Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
AbbVie
AbbVie
RemeGen Co., Ltd.
TORL Biotherapeutics, LLC
Mayo Clinic
Mayo Clinic
Massachusetts General Hospital
Gradalis, Inc.
AbbVie
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
Bristol-Myers Squibb
Corcept Therapeutics
M.D. Anderson Cancer Center
University Health Network, Toronto
University of Washington
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Emory University